Life expectancy and cost utility after total hip replacement.
In a prospective study of 410 cemented hip replacements in 372 patients with a mean age of 71 years, mortality after 8 years was 33%. Mortality for patients with osteoarthrosis was lower than in an age matched control population, probably because of a preoperative selection of patients. An estimate of costs and adjusted quality of life has shown that total hip replacement has a good cost utility even in the elderly patient. The conclusion of this study is that the indications for hip replacement in the elderly patient can be expanded. Such patients should undergo surgery earlier in the course of their disease.